Shatavari

Names and identification

Language	Name
English	Shatavari
Common Names	Wild Asparagus, Shatavari
Hindi	Shatavari, Satmuli
Sanskrit	Shatavari, Bahusuta
Latin/Botanical	Asparagus racemosus

Parts Used

• Root (tuberous)

Dosha Effects

Dosha	Effect
Vata	Decreases
Pitta	Decreases
Kapha	May Increase

Key Phytochemical Constituents

• Shatavarin I-IV (steroidal saponins)
• Racemosol
• Asparagamine A
• Isoflavones
• Mucilage

Therapeutic Actions (Karma)

• Galactogogue
• Adaptogen
• Phytoestrogenic
• Anti-ulcerogenic
• Immunomodulator
• Antioxidant
• Female reproductive tonic

How does it work?

• Phytoestrogenic activity via steroidal saponins (Shatavarins I-IV) binding estrogen receptor alpha (ERalpha), modulating gonadotropin levels
• Immunomodulation: Shatavarins stimulate immune cell proliferation and IgG secretion in dose-dependent manner
• Th1/Th2 cytokine balance modulation: stimulates IL-12 production while inhibiting IL-6
• Shatavarin I blocks oxytocin-induced uterine contractions (in vitro and in vivo) via glycoside-mediated competitive antagonism
• Antioxidant activity through polyphenol and flavonoid content scavenging reactive oxygen species
• Galactogogue effect attributed to increased prolactin levels mediated by steroidal saponins

How is it used traditionally?

Name means ‘she who possesses 100 husbands’ — referring to female reproductive benefits. Primary herb for Stri Roga (gynecological disorders). Used for Raktapitta (bleeding disorders) and Shukra Dhatu (reproductive tissue).

Where is it described in the classical texts?

• Charaka Samhita (Balya group)
• Sushruta Samhita
• Bhavaprakasha Nighantu
• Ashtanga Hridaya

What do recent clinical trials show?

• Gudise VS, Dasari MP, Kuricheti SSK 2024. Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial. Cureus. PMID 38725785 · doi:10.7759/cureus.57879
  Multicenter RCT demonstrated Shatavari root extract was effective and safe for managing menopausal symptoms including hot flashes, night sweats, and mood disturbances.
• Mahajan S, Avad P, Langade J 2025. Efficacy and Safety of Shatavari (Asparagus racemosus) Root Extract for Perimenopause: Randomized, Double-Blind, Placebo-Controlled Study. International journal of women’s health. PMID 41209045 · doi:10.2147/IJWH.S544267
  80 participants randomized to Shatavari 300 mg daily or placebo for 8 weeks. Shatavari root extract demonstrated effective and safe natural intervention for perimenopausal symptoms.
• Ademola J, Ajgaonkar A, Debnath T and others 2025. Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study. Frontiers in reproductive health. PMID 41394012 · doi:10.3389/frph.2025.1654503
  135 women aged 45-65 across three arms (Shatavari alone, Shatavari + Ashwagandha, placebo). Both Shatavari alone and the combination were effective; combination showed additive benefits for managing menopausal symptoms and overall health.
• Ademola J, Mahajan S, Srivathsan M and others 2026. Effects of Shatavari (Asparagus racemosus) Root Extract on Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-Arm, Parallel-Group, Placebo-Controlled Study. International journal of women’s health. PMID 41710148 · doi:10.2147/IJWH.S561213
  Standardized Shatavari root extract demonstrated safe and effective improvement in women’s sexual health outcomes, with additive effects when combined with Ashwagandha.
• Oyovwi MO, Chijiokwu EA, Ben-Azu B and others 2025. Shatavari (Asparagus racemosus): A Promising Ally for Fertility. Current nutrition reports. PMID 40974515 · doi:10.1007/s13668-025-00694-5
  Review consolidating evidence that Shatavari enhances fertility rates and improves breast milk quality and quantity, supporting its traditional use in postpartum care.

Recent safety updates

• Clinical trials report favorable safety profile at doses of 300-500 mg daily for up to 8 weeks
• Mild gastrointestinal complaints (loose stools, nausea) are the most common adverse effects, typically transient and dose-dependent
• Phytoestrogenic properties can interfere with estrogen-based medications and hormone replacement therapy (HRT)
• Contraindicated in hormone-sensitive conditions: certain cancers (breast, ovarian, uterine), endometriosis, uterine fibroids
• May reduce effectiveness of hormonal birth control pills by altering hormone levels or drug absorption
• Animal reproductive toxicity studies show no teratogenic effects at therapeutic doses, but rigorous human data still lacking
• Mild adverse events in clinical trials: loose stools, dizziness, nausea, headache - all resolving on discontinuation

Recommended Dosage

Root powder: 3-6g/day (with milk); Extract: 500mg-1g/day

Safety, contraindications and cautions

• Estrogen-sensitive conditions
• Kidney disorders (diuretic effect)
• May increase Kapha (edema/congestion)

What is it made of?

Part(s) Analyzed: Root tuber

Steroidal Saponins (Shatavarins)

• Shatavarin I-IV (8-12%)
• Sarsasapogenin
• Diosgenin
• Asparanin A-D

Isoflavones

• Racemosol
• Asparagamine A
• Racemofuran

Polysaccharides

• Arabinogalactan
• Glucomannans

Sterols

• Beta-sitosterol
• Stigmasterol

Analytical Methods: HPLC-ELSD (saponins), LC-MS/MS, UV spectrophotometry

Dosage forms and preparation

Dosage Forms: Churna (powder), Capsule, Tablet, Granules (Shatavari Kalpa), Ghrita (medicated ghee), Kwatha (decoction), Ksheerapaka (milk decoction), Soft gelatin capsule, Syrup

Standard Dosage: 3-6 g root powder per day; 500-1000 mg standardized extract twice daily; 1-2 tablespoons Shatavari Kalpa (granules) with milk; 10-20 mL syrup twice daily

Bioavailability: Shatavarin (steroidal saponin) has moderate oral bioavailability (20-30%) — improved 2-3x by milk co-administration (traditional Ksheerapaka method, which provides lipid and calcium for enhanced saponin solubilization). Racemosol and isoflavonoids are lipophilic with moderate absorption. Mucilage content (25-30%) slows gastric emptying and provides sustained release effect. Phytosome/phospholipid complex formulations improve bioavailability by 2.5-3x.

Optimal Timing: With warm milk (traditional vehicle for Stanya — galactagogue action and Vajikarana — reproductive tonic); morning and bedtime doses; after meals for GI-protective effects

Standardized Extract: Root extract (10:1 in 70% ethanol), standardized to NLT 40% saponins (as Shatavarin IV equivalents by HPLC-ELSD); or NLT 20% total saponins by gravimetric method. Aqueous extract standardized to NLT 30% polysaccharides for immunomodulatory applications.

Shelf Life: 24 months for churna; 36 months for standardized extract capsules; 12 months for Shatavari Kalpa (sugar-based granules); 6-12 months for Ghrita

Storage: Store below 25 deg C in airtight containers. Mucilage-rich powder is hygroscopic — maintain RH <50%. Ghrita in glass jars, protect from light. Kalpa in moisture-proof packaging.

Marker Compounds: Shatavarin I, Shatavarin IV, Racemosol, Asparagamine A, Racemofuran, Beta-sitosterol, Stigmasterol, Diosgenin

Extraction Methods

• Aqueous extraction (traditional)
• Hydroalcoholic extraction (50-70% ethanol)
• Milk decoction (Ksheerapaka — traditional bioenhanced form)
• Supercritical CO2 for saponin enrichment
• Spray-drying with maltodextrin for instant powder

Synergistic Combinations

• Ashwagandha (adaptogenic synergy — male + female reproductive health)
• Lodhra (gynecological formulations)
• Guduchi (immunomodulatory and galactagogue combination)
• Yashtimadhu (ulcer-healing and mucosal protective synergy)
• Vidari (Brihana — nourishing tonic combinations)
• Jeeraka (galactagogue formulations for lactating mothers)